The GH-2004 project: the response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-Caucasian amateur athletes
The GH-2004 project: the response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-Caucasian amateur athletes
Context: The GH-2000 team proposed a method based on IGF1 and type III pro-collagen (P-III-P) to detect exogenously administered GH. As previous studies involved predominantly white European athletes, it is important to assess whether the response of these markers to recombinant human GH (rhGH) differs with ethnicity.
Objective: To examine the response of serum IGF1 and P-III-P and GH-2000 score to rhGH in non-Caucasian amateur athletes.
Design: Double-blind placebo-controlled rhGH administration study.
Setting: Wellcome Trust Clinical Research Facility, Southampton General Hospital.
Subjects: The study included 31 male and 14 female amateur athletes of different ethnicities.
Intervention: The subjects were assigned to treatment with placebo or 0.1 IU/kg per day (low dose) or 0.2 IU/kg per day (high dose) rhGH for 28 days. Blood was collected weekly during treatment and on days 35, 42 and 84 during the washout period. Serum IGF1 and P-III-P were measured, and GH-2000 score was calculated.
Results: IGF1, P-III-P and GH-2000 score rose in response to both low- and high-dose GH in both men and women. When compared with the Caucasian volunteers of the previous GH-2000 study, mean baseline and placebo-treated P-III-P and GH-2000 score were lower in GH-2004 men and women. Post-GH, however, peak IGF1 or P-III-P did not differ between studies but the peak GH-2000 score was lower in GH-2004 men. There was no difference between studies in the maximal change in IGF1, P-III-P and GH-2000 score in response to GH in either gender.
Conclusions: These data do not support a significant ethnic effect on the peak or maximal response to rhGH.
45-54
Holt, Richard I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Erotokritou-Mulligan, Ioulietta
8bb8720a-eda7-4ad4-b969-0b35c5e5226c
McHugh, Cathy
490395d5-8da7-4c97-a0de-51b7e7e2b35c
Bassett, E. Eryl
fefd7f16-2045-4700-adaa-7cc6049933a4
Bartlett, Christiaan
ed9cba27-96ef-419e-824b-fabab5c7cba8
Fityan, Adam
fd9c1bbc-6bfb-49fb-9cb6-f9a16f8595f8
Bacon, Jenny L.
0a804d5c-38d2-46c1-a73b-a8c77ed02b83
Cowan, David A.
22bdafa8-cee8-481a-97d5-2687fcf325ca
Sonksen, Peter H.
b3cf05ef-65c2-4e9b-8d95-b7c3aaf532cd
July 2010
Holt, Richard I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Erotokritou-Mulligan, Ioulietta
8bb8720a-eda7-4ad4-b969-0b35c5e5226c
McHugh, Cathy
490395d5-8da7-4c97-a0de-51b7e7e2b35c
Bassett, E. Eryl
fefd7f16-2045-4700-adaa-7cc6049933a4
Bartlett, Christiaan
ed9cba27-96ef-419e-824b-fabab5c7cba8
Fityan, Adam
fd9c1bbc-6bfb-49fb-9cb6-f9a16f8595f8
Bacon, Jenny L.
0a804d5c-38d2-46c1-a73b-a8c77ed02b83
Cowan, David A.
22bdafa8-cee8-481a-97d5-2687fcf325ca
Sonksen, Peter H.
b3cf05ef-65c2-4e9b-8d95-b7c3aaf532cd
Holt, Richard I.G., Erotokritou-Mulligan, Ioulietta, McHugh, Cathy, Bassett, E. Eryl, Bartlett, Christiaan, Fityan, Adam, Bacon, Jenny L., Cowan, David A. and Sonksen, Peter H.
(2010)
The GH-2004 project: the response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-Caucasian amateur athletes.
European journal of endocrinology, 163 (1), .
(doi:10.1530/EJE-09-0978).
(PMID:20421332)
Abstract
Context: The GH-2000 team proposed a method based on IGF1 and type III pro-collagen (P-III-P) to detect exogenously administered GH. As previous studies involved predominantly white European athletes, it is important to assess whether the response of these markers to recombinant human GH (rhGH) differs with ethnicity.
Objective: To examine the response of serum IGF1 and P-III-P and GH-2000 score to rhGH in non-Caucasian amateur athletes.
Design: Double-blind placebo-controlled rhGH administration study.
Setting: Wellcome Trust Clinical Research Facility, Southampton General Hospital.
Subjects: The study included 31 male and 14 female amateur athletes of different ethnicities.
Intervention: The subjects were assigned to treatment with placebo or 0.1 IU/kg per day (low dose) or 0.2 IU/kg per day (high dose) rhGH for 28 days. Blood was collected weekly during treatment and on days 35, 42 and 84 during the washout period. Serum IGF1 and P-III-P were measured, and GH-2000 score was calculated.
Results: IGF1, P-III-P and GH-2000 score rose in response to both low- and high-dose GH in both men and women. When compared with the Caucasian volunteers of the previous GH-2000 study, mean baseline and placebo-treated P-III-P and GH-2000 score were lower in GH-2004 men and women. Post-GH, however, peak IGF1 or P-III-P did not differ between studies but the peak GH-2000 score was lower in GH-2004 men. There was no difference between studies in the maximal change in IGF1, P-III-P and GH-2000 score in response to GH in either gender.
Conclusions: These data do not support a significant ethnic effect on the peak or maximal response to rhGH.
This record has no associated files available for download.
More information
Published date: July 2010
Identifiers
Local EPrints ID: 166067
URI: http://eprints.soton.ac.uk/id/eprint/166067
ISSN: 0804-4643
PURE UUID: bb12068e-09cc-4fbd-b122-65ca9fd9a99c
Catalogue record
Date deposited: 21 Oct 2010 13:54
Last modified: 14 Mar 2024 02:45
Export record
Altmetrics
Contributors
Author:
Ioulietta Erotokritou-Mulligan
Author:
Cathy McHugh
Author:
E. Eryl Bassett
Author:
Christiaan Bartlett
Author:
Adam Fityan
Author:
Jenny L. Bacon
Author:
David A. Cowan
Author:
Peter H. Sonksen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics